Evidence map›Paper›PMID 21239559›Full record

ArticleApplied and environmental microbiology2011

Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA.

Ayako Ogawa, Soichi Furukawa, Shuhei Fujita, Jiro Mitobe, Taketo Kawarai, Naoki Narisawa, Tsuyoshi Sekizuka, Makoto Kuroda, Kuniyasu Ochiai, Hirokazu Ogihara and 6 more

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 79 citations in OpenAlex.

  1. Identification ofMicroorganisms · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Antibiotics (Basel, Switzerland) · 2023
    Review
  9. Adjunctive role of Q10 withFrontiers in cellular and infection microbiology · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. TheMicrobiology spectrum · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. The dental plaque biofilm matrix.Periodontology 2000 · 2021
    Review
  18. Article
  19. Protective Effects of the Probiotic BacteriumIranian journal of medical sciences · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Ayako OgawaDepartment of Bacteriology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Soichi Furukawa
Shuhei Fujita
Jiro Mitobe
Taketo Kawarai
Naoki Narisawa
Tsuyoshi Sekizuka
Makoto Kuroda
Kuniyasu Ochiai
Hirokazu Ogihara
Saori Kosono
Saori Yoneda
Haruo Watanabe
Yasushi Morinaga
Hiroshi Uematsu
Hidenobu Senpuku
National Institute of Infectious Diseases · JPNihon University · JPRIKEN · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral microbial flora consists of many beneficial species of bacteria that are associated with a healthy condition and control the progression of oral disease. Cooperative interactions between oral streptococci and the pathogens play important roles in the development of dental biofilms in the oral cavity. To determine the roles of oral streptococci in multispecies biofilm development and the effects of the streptococci in biofilm formation, the active substances inhibiting Streptococcus mutans biofilm formation were purified from Streptococcus salivarius ATCC 9759 and HT9R culture supernatants using ion exchange and gel filtration chromatography. Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry analysis was performed, and the results were compared to databases. The S. salivarius HT9R genome sequence was determined and used to indentify candidate proteins for inhibition. The candidates inhibiting biofilms were identified as S. salivarius fructosyltransferase (FTF) and exo-beta-d-fructosidase (FruA). The activity of the inhibitors was elevated in the presence of sucrose, and the inhibitory effects were dependent on the sucrose concentration in the biofilm formation assay medium. Purified and commercial FruA from Aspergillus niger (31.6% identity and 59.6% similarity to the amino acid sequence of FruA from S. salivarius HT9R) completely inhibited S. mutans GS-5 biofilm formation on saliva-coated polystyrene and hydroxyapatite surfaces. Inhibition was induced by decreasing polysaccharide production, which is dependent on sucrose digestion rather than fructan digestion. The data indicate that S. salivarius produces large quantities of FruA and that FruA alone may play an important role in multispecies microbial interactions for sucrose-dependent biofilm formation in the oral cavity.

Indexed as

Anti-Bacterial AgentsAspergillus nigerBacterial ProteinsBiofilmsChromatography, GelFungal ProteinsGlycoside HydrolasesHexosyltransferasesNigerSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStreptococcus mutansSucroseAnti-Bacterial AgentsBacterial Proteinsfructan beta-fructosidaseFungal ProteinsGlycoside HydrolasesHexosyltransferasesinulosucraseSucrose

Identifiers

PMID21239559
PMCPMC3067281
OpenAlexW2040233543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.